Imatinib Drug Market Report

Global Imatinib Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jan 26, 2021
  • PAGES：140
  • REPORT CODE：GMM610839
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.

    Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.

    The Imatinib Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period. The research provides insights for the global Imatinib Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Imatinib Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Imatinib Drug Market Segmentations:

    By Players:

    • Dr Reddy's Laboratories

    • Sun Pharmaceuticals

    • Novartis

    • Glenmark Pharmaceuticals Ltd

    • Cipla Inc

    • Sanofi SA

    • Actavis Generics

    • Mylan Pharms Inc

    • Teva Pharmaceutical Industries Ltd

    • Apotex Inc

    By Types:

    • Tablets

    • Capsules

    By End-User:

    • Chronic Myelogenous Leukemia

    • Gastrointestinal Stromal Tumors

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Imatinib Drug Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Imatinib Drug Market Size and Growth Rate of Tablets from 2014 to 2026

      • 1.3.2 Global Imatinib Drug Market Size and Growth Rate of Capsules from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Imatinib Drug Market Size and Growth Rate of Chronic Myelogenous Leukemia from 2014 to 2026

      • 1.4.2 Global Imatinib Drug Market Size and Growth Rate of Gastrointestinal Stromal Tumors from 2014 to 2026

      • 1.4.3 Global Imatinib Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Imatinib Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Imatinib Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Imatinib Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Imatinib Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Imatinib Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Imatinib Drug Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Imatinib Drug by Major Types

      • 3.4.1 Imatinib Drug Market Size and Growth Rate of Tablets

      • 3.4.2 Imatinib Drug Market Size and Growth Rate of Capsules

    4 Segmentation of Imatinib Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Imatinib Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Imatinib Drug in Chronic Myelogenous Leukemia

      • 4.4.2 Market Size and Growth Rate of Imatinib Drug in Gastrointestinal Stromal Tumors

      • 4.4.3 Market Size and Growth Rate of Imatinib Drug in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Imatinib Drug Production Analysis by Major Regions

    • 5.2 Global Imatinib Drug Consumption Analysis by Major Regions

    • 5.3 Global Imatinib Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Imatinib Drug Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Imatinib Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Imatinib Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Imatinib Drug Production, Import, Consumption and Export Analysis

    6 Product Commodity of Imatinib Drug Market in Major Countries

    • 6.1 Top 5 Export Countries in Imatinib Drug market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Imatinib Drug market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Imatinib Drug market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Imatinib Drug market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Imatinib Drug market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Imatinib Drug market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Imatinib Drug Landscape Analysis

    • 7.1 North America Imatinib Drug Landscape Analysis by Major Types

    • 7.2 North America Imatinib Drug Landscape Analysis by Major End-Users

    • 7.3 North America Imatinib Drug Landscape Analysis by Major Countries

      • 7.3.1 United States Imatinib Drug Market Volume and Growth Rate

      • 7.3.2 Canada Imatinib Drug Market Volume and Growth Rate

      • 7.3.3 Mexico Imatinib Drug Market Volume and Growth Rate

    8 Europe Imatinib Drug Landscape Analysis

    • 8.1 Europe Imatinib Drug Landscape Analysis by Major Types

    • 8.2 Europe Imatinib Drug Landscape Analysis by Major End-Users

    • 8.3 Europe Imatinib Drug Landscape Analysis by Major Countries

      • 8.3.1 Germany Imatinib Drug Market Volume and Growth Rate

      • 8.3.2 UK Imatinib Drug Market Volume and Growth Rate

      • 8.3.3 France Imatinib Drug Market Volume and Growth Rate

      • 8.3.4 Italy Imatinib Drug Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Imatinib Drug Market Volume and Growth Rate

      • 8.3.6 Spain Imatinib Drug Market Volume and Growth Rate

      • 8.3.7 Belgium Imatinib Drug Market Volume and Growth Rate

      • 8.3.8 Poland Imatinib Drug Market Volume and Growth Rate

      • 8.3.9 Russia Imatinib Drug Market Volume and Growth Rate

      • 8.3.10 Turkey Imatinib Drug Market Volume and Growth Rate

    9 Asia Pacific Imatinib Drug Landscape Analysis

    • 9.1 Asia Pacific Imatinib Drug Landscape Analysis by Major Types

    • 9.2 Asia Pacific Imatinib Drug Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Imatinib Drug Landscape Analysis by Major Countries

      • 9.3.1 China Imatinib Drug Market Volume and Growth Rate

      • 9.3.2 Japan Imatinib Drug Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Imatinib Drug Market Volume and Growth Rate

      • 9.3.4 India Imatinib Drug Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Imatinib Drug Market Volume and Growth Rate

      • 9.3.6 South Korea Imatinib Drug Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Imatinib Drug Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Imatinib Drug Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Imatinib Drug Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Imatinib Drug Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Imatinib Drug Market Volume and Growth Rate

      • 10.3.2 Brazil Imatinib Drug Market Volume and Growth Rate

      • 10.3.3 Nigeria Imatinib Drug Market Volume and Growth Rate

      • 10.3.4 South Africa Imatinib Drug Market Volume and Growth Rate 

      • 10.3.5 Argentina Imatinib Drug Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Dr Reddy's Laboratories

      • 11.1.1 Dr Reddy's Laboratories Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sun Pharmaceuticals

      • 11.2.1 Sun Pharmaceuticals Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Novartis

      • 11.3.1 Novartis Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Glenmark Pharmaceuticals Ltd

      • 11.4.1 Glenmark Pharmaceuticals Ltd Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Cipla Inc

      • 11.5.1 Cipla Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Sanofi SA

      • 11.6.1 Sanofi SA Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Actavis Generics

      • 11.7.1 Actavis Generics Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Mylan Pharms Inc

      • 11.8.1 Mylan Pharms Inc Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Teva Pharmaceutical Industries Ltd

      • 11.9.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Apotex Inc

      • 11.10.1 Apotex Inc Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 91 Figures and 152 Tables)

    • Figure Product Picture

    • Figure Imatinib Drug Market Size and Growth Rate of Tablets from 2014 to 2026

    • Figure Imatinib Drug Market Size and Growth Rate of Capsules from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Imatinib Drug Market Size and Growth Rate of Chronic Myelogenous Leukemia from 2014 to 2026

    • Figure Global Imatinib Drug Market Size and Growth Rate of Gastrointestinal Stromal Tumors from 2014 to 2026

    • Figure Global Imatinib Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Imatinib Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Imatinib Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Imatinib Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Imatinib Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Imatinib Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Tablets

    • Figure Market Size and Growth Rate of Capsules

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Imatinib Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Imatinib Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Chronic Myelogenous Leukemia

    • Figure Market Size and Growth Rate of Gastrointestinal Stromal Tumors

    • Figure Market Size and Growth Rate of Others

    • Table Global Imatinib Drug Production by Major Regions

    • Table Global Imatinib Drug Production Share by Major Regions

    • Figure Global Imatinib Drug Production Share by Major Regions in 2014

    • Figure Global Imatinib Drug Production Share by Major Regions in 2018

    • Figure Global Imatinib Drug Production Share by Major Regions in 2026

    • Table Global Imatinib Drug Consumption by Major Regions

    • Table Global Imatinib Drug Consumption Share by Major Regions

    • Figure Global Imatinib Drug Consumption Share by Major Regions in 2014

    • Figure Global Imatinib Drug Consumption Share by Major Regions in 2018

    • Figure Global Imatinib Drug Consumption Share by Major Regions in 2026

    • Table North America Imatinib Drug Production, Import, Consumption and Export Analysis

    • Table Europe Imatinib Drug Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Imatinib Drug Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Imatinib Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Imatinib Drug market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Imatinib Drug market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Imatinib Drug market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Imatinib Drug market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Imatinib Drug Consumption by Types from 2014 to 2026

    • Table North America Imatinib Drug Consumption Share by Types from 2014 to 2026

    • Figure North America Imatinib Drug Consumption Share by Types in 2014

    • Figure North America Imatinib Drug Consumption Share by Types in 2018

    • Figure North America Imatinib Drug Consumption Share by Types in 2026

    • Table North America Imatinib Drug Consumption by End-Users from 2014 to 2026

    • Table North America Imatinib Drug Consumption Share by End-Users from 2014 to 2026

    • Figure North America Imatinib Drug Consumption Share by End-Users in 2014

    • Figure North America Imatinib Drug Consumption Share by End-Users in 2018

    • Figure North America Imatinib Drug Consumption Share by End-Users in 2026

    • Table North America Imatinib Drug Consumption by Major Countries from 2014 to 2026

    • Table North America Imatinib Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Imatinib Drug Consumption Share by Major Countries in 2014

    • Figure North America Imatinib Drug Consumption Share by Major Countries in 2018

    • Figure North America Imatinib Drug Consumption Share by Major Countries in 2026

    • Figure United States Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Imatinib Drug Consumption by Types from 2014 to 2026

    • Table Europe Imatinib Drug Consumption Share by Types from 2014 to 2026

    • Figure Europe Imatinib Drug Consumption Share by Types in 2014

    • Figure Europe Imatinib Drug Consumption Share by Types in 2018

    • Figure Europe Imatinib Drug Consumption Share by Types in 2026

    • Table Europe Imatinib Drug Consumption by End-Users from 2014 to 2026

    • Table Europe Imatinib Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Imatinib Drug Consumption Share by End-Users in 2014

    • Figure Europe Imatinib Drug Consumption Share by End-Users in 2018

    • Figure Europe Imatinib Drug Consumption Share by End-Users in 2026

    • Table Europe Imatinib Drug Consumption by Major Countries from 2014 to 2026

    • Table Europe Imatinib Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Imatinib Drug Consumption Share by Major Countries in 2014

    • Figure Europe Imatinib Drug Consumption Share by Major Countries in 2018

    • Figure Europe Imatinib Drug Consumption Share by Major Countries in 2026

    • Figure Germany Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure France Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Imatinib Drug Consumption by Types from 2014 to 2026

    • Table Asia Pacific Imatinib Drug Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Imatinib Drug Consumption Share by Types in 2014

    • Figure Asia Pacific Imatinib Drug Consumption Share by Types in 2018

    • Figure Asia Pacific Imatinib Drug Consumption Share by Types in 2026

    • Table Asia Pacific Imatinib Drug Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Imatinib Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Imatinib Drug Consumption Share by End-Users in 2014

    • Figure Asia Pacific Imatinib Drug Consumption Share by End-Users in 2018

    • Figure Asia Pacific Imatinib Drug Consumption Share by End-Users in 2026

    • Table Asia Pacific Imatinib Drug Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Imatinib Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Imatinib Drug Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Imatinib Drug Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Imatinib Drug Consumption Share by Major Countries in 2026

    • Figure China Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandImatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure India Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Imatinib Drug Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Imatinib Drug Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Imatinib Drug Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Imatinib Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Imatinib Drug Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Imatinib Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Imatinib Drug Consumption Share by Major Countries in 2026

    • Figure GCC Countries Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Imatinib Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Dr Reddy's Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories

    • Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories

    • Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories

    • Table Product and Service Introduction of Dr Reddy's Laboratories

    • Table Company Profile and Development Status of Sun Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sun Pharmaceuticals

    • Table Product and Service Introduction of Sun Pharmaceuticals

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Glenmark Pharmaceuticals Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark Pharmaceuticals Ltd

    • Figure Sales and Growth Rate Analysis of Glenmark Pharmaceuticals Ltd

    • Figure Revenue and Market Share Analysis of Glenmark Pharmaceuticals Ltd

    • Table Product and Service Introduction of Glenmark Pharmaceuticals Ltd

    • Table Company Profile and Development Status of Cipla Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla Inc

    • Figure Sales and Growth Rate Analysis of Cipla Inc

    • Figure Revenue and Market Share Analysis of Cipla Inc

    • Table Product and Service Introduction of Cipla Inc

    • Table Company Profile and Development Status of Sanofi SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA

    • Figure Sales and Growth Rate Analysis of Sanofi SA

    • Figure Revenue and Market Share Analysis of Sanofi SA

    • Table Product and Service Introduction of Sanofi SA

    • Table Company Profile and Development Status of Actavis Generics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Generics

    • Figure Sales and Growth Rate Analysis of Actavis Generics

    • Figure Revenue and Market Share Analysis of Actavis Generics

    • Table Product and Service Introduction of Actavis Generics

    • Table Company Profile and Development Status of Mylan Pharms Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharms Inc

    • Figure Sales and Growth Rate Analysis of Mylan Pharms Inc

    • Figure Revenue and Market Share Analysis of Mylan Pharms Inc

    • Table Product and Service Introduction of Mylan Pharms Inc

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of Apotex Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex Inc

    • Figure Sales and Growth Rate Analysis of Apotex Inc

    • Figure Revenue and Market Share Analysis of Apotex Inc

    • Table Product and Service Introduction of Apotex Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US